FDA says no, thank you to Xpovio’s cancer expansion bid, prompting Karyopharm to run new study
FDA says no, thank you to Xpovio’s cancer expansion bid, [...]
FDA says no, thank you to Xpovio’s cancer expansion bid, [...]
A year later at the SOTU, deja vu all over [...]
Eli Lilly’s Medicaid rebate payments under fire as whistleblower lawsuit [...]
A DOE-Based Approach to Optimizing T-Cell Expansion ncavazza Tue, 03/01/2022 [...]
FibroGen’s roxadustat safety mess draws SEC scrutiny as AstraZeneca-partnered anemia [...]
COPD Foundation links arms with Ena on antiviral nasal spray [...]
Trevi revs up extended-release opioid cough program, exiting phase 2 [...]
Sanofi chases fourth Dupixent nod after late-stage eosinophilic esophagitis trial [...]
Judge backs Johnson & Johnson in bankruptcy ploy for talc [...]
EMA expands nods for BMS, Eli Lilly, Novartis drugs and [...]